Profilo
Trista Morrison is currently Director at Network of Tyrosinemia Advocates, Inc. and Chief of Staff & Chief Corporate Affairs Officer at Voyager Therapeutics, Inc. Former roles include Director-Corporate Communications at Ironwood Pharmaceuticals, Inc., Head-Media Relations at Gemin X Pharmaceuticals US, Inc., and Chief Communications Officer at Saniona AB. Education includes an undergraduate degree from Tulane University (Louisiana).
Posizioni attive di Trista Morrison
| Società | Posizione | Inizio |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 19/09/2022 |
Network of Tyrosinemia Advocates, Inc. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Trista Morrison
| Società | Posizione | Fine |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Public Communications Contact | - |
| SANA AB | Public Communications Contact | - |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Public Communications Contact | - |
Formazione di Trista Morrison
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Health Technology |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Saniona AB
Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Network of Tyrosinemia Advocates, Inc. |
















